Q1 Earnings Estimate for AXSM Issued By HC Wainwright
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Axsome Therapeutics in a research note issued to investors on Thursday, February 20th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings per share of $0.11 for the quarter. […]
